Papers: 10.3390/jcm10194543

https://doi.org/10.3390/jcm10194543

Benefits of a Disease Management Program for Sickle Cell Disease in Germany 2011–2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome

Cited by: 3
Author(s): Joachim Kunz, Andreas Schlotmann, Andrea Daubenbüchel, Stephan Lobitz, Andrea Jarisch, Regine Grosse, Holger Cario, Lena Oevermann, Dani Hakimeh, L. Tagliaferri, Andreas E. Kulozik
Published: about 5 years ago

Software Mentions 1